🚨Finally a new drug approval for CKD in T1D! 1st drug in 30 years
🫘
#Finerenone reduces urinary albumin-to-creatinine ratio (UACR) in adults with CKD & T1D, which slows CKD progression
Congratulations to
@Bayer for studying this important group
#FINEONE
Now let’s do more outcome studies of T1D with other drugs that are being used off label. They deserve evidence based care
breakthrought1d.org/news-and…